Condition: Diabetic Foot Ulcer · Venous Leg Ulcer · Surgical Wound Dehiscence · Sponsor: Medaxis, LLC
Prospective, single-blinded, single-center, parallel group, randomized controlled trial (RCT) to assess rate and frequency of wound healing and associated financial savings, when using Medaxis debritom+ versus standard of care as a choice of debridement method, where both arms follow normal wound care practice in use of advanced wound care treatments.
This description comes directly from the study's public registry record.
Sharona Segal-Leibovich · 646-369-1570 · ssegal-leibovich@namsa.com
Amy Jo Johnson · amyjo.johnson@medaxis.us
Always discuss trial participation with your own doctor first.
| MCR Health, Inc. | Bradenton, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04920253